- セベロ・オチョア
- 昭和
- 米国
「セヴェロ・オチョア」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 8
- 期間を指定 57
- 日付指定なし 57
- 種類
- 写真 57
- グラフィックス 0
- 映像 0
- 向き
- 縦 6
- 横 51
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 51
- モノクロ 6
- 古い順
- 1
- 古い順
1967年09月28日（ＳＥＶＥＲＯ ＯＣＨＯＡ） セベロ・オチョア米国、ニューヨーク大学教授＝１９５９（昭和３４）年度ノーベル医学生理学賞受賞＝１９６７（昭和４２）年８月２１日撮影
商品コード: 2006033000390
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910581
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman talks to a health worker before receiving the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003750
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A person receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004086
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health worker prepares the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004168
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health worker prepares the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004140
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910029
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910686
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910688
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: Sign of the vaccination device put in place to inoculate the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061000249
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: Two people receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004116
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A man receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910587
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman hands over her documentation to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003960
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A man prepares to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004304
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: Health workers inoculate patients with the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003770
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A line of patients waiting to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003845
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A line of patients waiting to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003870
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health worker prepares the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004158
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: Two people receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910809
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health employee shows a dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003749
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910687
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A man receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021060910717
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A line of patients waiting to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003869
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A person receives the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004290
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health employee next to a sign of the vaccination device put in place to inoculate the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003761
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A woman hands over her documentation to receive the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061004011
2021年06月09日Madrid begins to vaccinate citizens aged 40 to 49 years against Covid-19June 9, 2021, Leganés, (Madrid, Madrid, Spain: A health worker prepares the first dose of the Pfizer-BioNTech vaccine against Covid-19, on June 9, 2021, at the Severo Ochoa Hospital in Leganés, Leganés, Madrid, (Spain). The Community of Madrid begins this Wednesday to vaccinate citizens aged 40 to 49 years, so that more than 466,000 Madrid citizens born between 1975 and 1972 (aged 46 to 49 years) will begin today to receive their appointment to go to public hospitals to receive the first dose. 46.2% of the target population in the Community of Madrid (aged 16 and over) have received their first dose and 25.1% are fully immunized...09 JUNE 2021;VACCINE;COVID;PZIFER;40 YEARS;MADRID;CORONAVIRUS..A. Pérez Meca / Europa Press..06/09/2021 (Credit Image: © A. PéRez Meca/Contacto via ZUMA Press)、クレジット：©Ａ． ＰéＲｅｚ Ｍｅｃａ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021061003961
2021年11月15日Ayuso receives the City of Leganés award in Leganés (Madrid)November 15, 2021, Madrid, Spain: The president of the Community of Madrid, Isabel DÃÂaz Ayuso, presents the City of Leganés award to the director of the Severo Ochoa University Hospital, Domingo del Cacho Malo, on 15 November 2021, in Leganés, Madrid, (Spain). Awarded by the Leganés Business Union (UNELE), with this award they want to reward the work of companies and institutions that promote the business and productive fabric of the municipality of Madrid...15 NOVEMBER 2021;AWARD;MADRID;Madrid OF LEGANÃâ°S;BUSINESS UNION OF LEGANÃâ°S..Gustavo Valiente / Europa Press..11/15/2021 (Credit Image: © Gustavo Valiente/Contacto via ZUMA Press)、クレジット：©Ｇｕｓｔａｖｏ Ｖａｌｉｅｎｔｅ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ， ａｎｄ ＵＫ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021111605810
2021年11月15日Ayuso receives the City of Leganés award in Leganés (Madrid)November 15, 2021, Madrid, Spain: The president of the Community of Madrid, Isabel DÃÂaz Ayuso, presents an award to the director of the Severo Ochoa University Hospital, Domingo del Cacho Malo, on 15 November 2021, in Leganés, Madrid, (Spain). Awarded by the Business Union of Leganés (UNELE), with this award they want to reward the work of companies and institutions that promote the business and productive fabric of the municipality of Madrid...15 NOVEMBER 2021;AWARD;MADRID;Madrid OF LEGANÃâ°S;BUSINESS UNION OF LEGANÃâ°S..Gustavo Valiente / Europa Press..11/15/2021 (Credit Image: © Gustavo Valiente/Contacto via ZUMA Press)、クレジット：©Ｇｕｓｔａｖｏ Ｖａｌｉｅｎｔｅ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ， ａｎｄ ＵＫ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021111605625
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001105
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001731
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021002165
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001718
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001700
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001085
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001790
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001781
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001968
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001723
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001805
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021000963
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001083
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001065
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001079
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001090
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001740
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001724
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001996
2022年02月09日Portraits to Margarita de ValFebruary 9, 2022, Madrid (Spain, Spain: Spanish chemist, virologist and immunologist Margarita de Val poses for Europa Press at the Severo Ochoa Molecular Biology Center on February 9, 2022, in Madrid (Spain). Margarita de Val is a research scientist at the Spanish National Research Council on the immune response to viral infections and a research scientist at the Severo Ochoa Molecular Biology Center...09 FEBRUARY 2022;SCIENTIFIC..Jesús HellÃÂn / Europa Press..02/09/2022 (Credit Image: © JesúS HellÃÂN/Contacto via ZUMA Press)、クレジット：©ＪｅｓúＳ ＨｅｌｌÃÂＮ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022021001734
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: (L-R) The cardiologist of the Severo Ochoa Hospital in Leganés, Alberto Esteban; the nurse of the Cardiology Service of the Hospital ClÃÂnico San Carlos in Madrid, Mónica Pérez and the secretary of CardioAlianza and cardiovascular patient, Tomás Fajardo, pose at the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the SNS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062608357
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: (L-R) The cardiologist of the Severo Ochoa Hospital in Leganés, Alberto Esteban; the nurse of the Cardiology Service of the Hospital ClÃÂnico San Carlos in Madrid, Mónica Pérez; the secretary of CardioAlianza and cardiovascular patient, Tomás Fajardo; and the editor-in-chief of Health of Europa Press, Eva Concha, intervene in the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the SNS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062608427
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: Alberto Esteban, cardiologist at the Severo Ochoa Hospital in Leganés, Spain, speaks at the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the NHS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062608471
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: Alberto Esteban, cardiologist at the Severo Ochoa Hospital in Leganés, Spain, speaks at the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the NHS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062608378
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: (L-R) The cardiologist of the Severo Ochoa Hospital in Leganés, Alberto Esteban; the nurse of the Cardiology Service of the Hospital ClÃÂnico San Carlos in Madrid, Mónica Pérez and the secretary of CardioAlianza and cardiovascular patient, Tomás Fajardo, leave the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the SNS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062610268
2022年06月23日Bayer and Europa Press Meeting on Heart Failure in SpainJune 23, 2022, Madrid, Spain: (L-R) The cardiologist of the Severo Ochoa Hospital in Leganés, Alberto Esteban; the nurse of the Cardiology Service of the Hospital ClÃÂnico San Carlos in Madrid, Mónica Pérez; the secretary of CardioAlianza and cardiovascular patient, Tomás Fajardo; and the editor-in-chief of Health of Europa Press, Eva Concha, intervene in the digital meeting of Bayer and Europa Press on ‘Heart failure in Spain: a challenge for the SNS‘, on June 23, 2022, in Madrid (Spain)...23 JUNE 2022;BAYER;EUROPA PRESS;HEART FAILURE;SPAIN;LABORATORY;FAMACEUTICA..Fernando Sánchez / Europa Press..06/23/2022 (Credit Image: © Fernando SáNchez/Contacto via ZUMA Press)、クレジット：©Ｆｅｒｎａｎｄｏ ＳáＮｃｈｅｚ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022062610304
2022年08月25日From Hippocrates to Gregorio Marañón or Isabel Zendal, the trace of medicine in the streets of MadridAugust 25, 2022, Madrid, Spain: Monument to the physician and scientist Severo Ochoa at the Complutense University of Madrid, on August 25, 2022, in Madrid (Spain). This statue made by VÃÂctor Ochoa, nephew of the physician and biochemist, is one of the points in the Spanish capital where the name of some important references in the world of medicine survives. From public spaces to streets, sculptures, and hospital names, the trace of medicine is noticeable in the streets of Madrid...25 AUGUST 2022;Madrid;SCULPTURE;TRIBUTE;MEDICINE..Ricardo Rubio / Europa Press..08/25/2022 (Credit Image: © Ricardo Rubio/Contacto via ZUMA Press)、クレジット：©Ｒｉｃａｒｄｏ Ｒｕｂｉｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022082604871
2022年08月25日From Hippocrates to Gregorio Marañón or Isabel Zendal, the trace of medicine in the streets of MadridAugust 25, 2022, Madrid, Spain: Monument to the physician and scientist Severo Ochoa at the Complutense University of Madrid, on August 25, 2022, in Madrid (Spain). This statue made by VÃÂctor Ochoa, nephew of the physician and biochemist, is one of the points in the Spanish capital where the name of some important references in the world of medicine survives. From public spaces to streets, sculptures, and hospital names, the trace of medicine is noticeable in the streets of Madrid...25 AUGUST 2022;Madrid;SCULPTURE;TRIBUTE;MEDICINE..Ricardo Rubio / Europa Press..08/25/2022 (Credit Image: © Ricardo Rubio/Contacto via ZUMA Press)、クレジット：©Ｒｉｃａｒｄｏ Ｒｕｂｉｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2022082604830
- 1
